Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
9 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities    
Net loss $ (2,323,235) $ (3,036,803)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 53,171 53,170
Amortization of debt discount 1,051,707 401,313
Change in fair value of derivative liability (1,116,500) 239,000
Change in fair value of warrant liability 47,000 436,000
Financing costs related to convertible debentures 1,361,735 895,640
Shares issued for services 0 100,000
Changes in operating assets and liabilities:    
Inventory (4,200) 0
Prepaid expenses and other current assets (543) 42,448
Accounts payable (1,403) 43,129
Other accrued expenses 103,732 108,846
Accrued interest 145,641 36,646
Cash used in operating activities (682,895) (680,611)
Cash flows from investing activities    
Cash paid for fixed assets (5,350) 0
Cash paid for construction in progress (75,404) 0
Cash used in investing activitites (80,754) 0
Cash flows from financing activities    
Payments on bank loan (5,689) (4,684)
Payment of related party notes payable 0 0
Repayment Line of Credit Short-term (3,153) (2,486)
Notes receivable 150,000 0
Proceeds from sale of stock 15,400 25,000
Proceeds from issuance of stock under equity financing agreement 164,516 0
Proceeds from convertible debentures 565,800 730,200
Proceeds from convertible debentures, related party 0 180,000
Payments on convertible debentures (123,037) (227,500)
Payments on convertible debentures, related party 0 (92,400)
Cash provided by financing activities 763,837 608,130
Net change in cash 188 (72,481)
Cash at beginning of period 24,280 88,195
Cash at end of period 24,468 15,714
Interest paid 96,018 87,740
Supplemental Disclosure of Non-Cash Investing and Financing Activities:    
Shares issued upon conversion 1,128,068 0
Shares issued upon exercise of warrants 150,000 0
Notes receivable for convertible debentures 90,000 131,200
Common shares exchanged for Series A Preferred Shares 500 0
Cashless exercise of warrants $ 0 $ 67,000